The periodontal disease treatment sector is expanding as rising dental disorders, greater awareness of preventive oral care, and advances in regenerative therapies encourage patients and healthcare providers to seek more effective treatment options. The global sector was valued at approximately USD 2.94 billion in 2025 and is projected to reach USD 6.23 billion by 2035, growing at a CAGR of 7.80% from 2026 to 2035.
The growing focus on early intervention, minimally invasive procedures, digital dentistry, and tissue regeneration is creating new opportunities across dental clinics, hospitals, and specialty periodontal centers.
Download a Sample Report: https://www.precedenceresearch.com/sample/8251
Why Periodontal Disease Treatment Is Gaining Strong Momentum
Periodontal disease affects the tissues supporting the teeth and can progress from gingivitis to more advanced forms of periodontitis. Treatment typically focuses on controlling infection and inflammation, reducing periodontal pockets, preserving supporting tissues, and restoring damaged structures.
Treatment options include non-surgical therapy, surgical procedures, adjunctive medications, and regenerative approaches. Increasing awareness of oral hygiene and routine dental examinations is encouraging earlier diagnosis and intervention.
The relationship between oral health and broader health outcomes is also attracting greater attention. This is encouraging healthcare systems and dental professionals to place greater emphasis on prevention, regular monitoring, and long-term periodontal care.
AI Is Bringing Powerful Changes to Periodontal Care
Artificial intelligence is becoming an important tool in modern periodontal care. AI-based systems can analyze dental radiographs and clinical information to identify patterns associated with bone loss and periodontal disease progression.
These technologies can support:
- Early detection of periodontal changes
- Radiographic analysis
- Patient risk assessment
- Personalized treatment planning
- Follow-up and recall scheduling
- Clinical decision support
AI can reduce diagnostic uncertainty and help dental professionals identify changes earlier, potentially improving treatment planning and long-term patient management.
Regenerative Dentistry Is Creating New Possibilities
One of the most important developments is the shift from simply controlling periodontal damage toward restoring lost tissue.
Regenerative procedures may involve bone grafts, guided tissue regeneration, membranes, and biologic materials. As clinical evidence and material technologies continue to improve, these approaches are becoming more accessible to dental professionals.
The regenerative therapy segment is expected to grow at a CAGR of 8.6% from 2026 to 2035, making it one of the most promising areas within periodontal treatment.
Chronic Periodontitis Remains the Leading Disease Type
Chronic periodontitis accounted for 52.7% of the sector in 2025, making it the largest disease segment.
Its dominant position is linked to its long-term nature and the need for repeated evaluation, scaling, root planing, maintenance therapy, and monitoring. Patients may require ongoing periodontal care to control disease progression and preserve oral function.
Meanwhile, aggressive periodontitis is expected to grow at a CAGR of 7.4%, supported by better diagnostic capabilities and increasing clinical awareness of rapidly progressing periodontal damage.
Non-Surgical Treatment Continues to Lead
The non-surgical periodontal therapy segment held 41.8% of the sector in 2025.
Scaling and root planing remain widely used because they are practical, effective, repeatable, and available across a broad range of dental practices. These procedures provide an important first-line approach for controlling periodontal infection and reducing inflammation.
The regenerative therapy segment, however, is gaining momentum as patients and clinicians place greater value on long-term tissue preservation and restoration.
Moderate Disease Severity Represents the Largest Segment
The moderate disease segment accounted for 43.7% in 2025.
This stage represents an important point for clinical intervention because patients may already have visible symptoms such as gum bleeding and periodontal changes while significant irreversible damage may still be limited.
The severe segment is projected to expand at a 7.6% CAGR, supported by demand for surgical procedures, regenerative treatments, and long-term supportive care.
Dental Clinics Remain the Primary Care Setting
Dental clinics accounted for 57.6% of the sector in 2025, reflecting their role as the first point of contact for routine oral examinations, diagnosis, and periodontal treatment.
The accessibility of dental clinics makes them important centers for preventive care and ongoing periodontal maintenance.
Specialty periodontal centers are expected to expand at a CAGR of 8.0%, supported by increasing referrals for complex cases and greater availability of advanced technologies and specialized procedures.
North America Holds the Leading Position
North America accounted for approximately 34.1% of the global sector in 2025.
The region benefits from developed dental infrastructure, strong awareness of oral healthcare, advanced diagnostic technologies, and increasing adoption of digital dentistry.
The United States remains the largest contributor in the region. Its strong network of dental practices, advanced periodontal procedures, and continued investment in digital technologies support ongoing expansion.
Asia Pacific Is Accelerating Rapidly
Asia Pacific is expected to register the fastest growth during the forecast period.
Rising healthcare spending, increasing urbanization, growing dental clinic networks, and greater awareness of oral health are improving access to periodontal treatment across the region.
China is an important contributor, supported by expanding dental infrastructure and growing demand for advanced oral healthcare. As awareness improves, patients are increasingly moving from delayed treatment toward preventive and earlier periodontal care.
How Leading Companies Are Positioning
The competitive landscape includes dental technology companies, biomaterial manufacturers, implant specialists, and oral healthcare providers.
Dentsply Sirona continues to strengthen its position through digital dentistry, dental equipment, and clinical solutions.
Institut Straumann remains a leading player in implantology and regenerative oral care, with a strong focus on advanced treatment technologies.
Geistlich Pharma is well positioned in regenerative dentistry through biomaterials used for bone and tissue regeneration.
Envista, ZimVie, Zimmer Biomet, and COLTENE are also expanding their capabilities across dental instruments, implants, biomaterials, and clinical technologies.
Companies are increasingly focusing on regenerative solutions, digital diagnostics, minimally invasive procedures, biomaterials, and AI-supported workflows.
Recent Developments
In March 2026, Sunstar’s GUM brand launched a global “Let’s Talk Oral Health” educational series focused on increasing awareness of periodontal science among healthcare professionals and patients.
In October 2025, Oral Biolife secured seed funding to advance non-invasive regenerative therapies designed to restore bone and soft tissue, highlighting growing interest in biologically driven periodontal treatment approaches.
What Comes Next for Periodontal Treatment
The future of periodontal treatment is moving toward earlier detection, personalized care, regenerative dentistry, and digitally supported clinical workflows.
Traditional non-surgical approaches will remain essential, while advanced regenerative therapies are expected to gain greater importance. AI could further improve diagnostic consistency, risk assessment, and treatment planning.
As patients become more proactive about oral health, the emphasis will increasingly shift from treating advanced periodontal damage to preventing progression and preserving healthy teeth and supporting tissues for longer.
Buy this report: https://www.precedenceresearch.com/checkout/8251
About Us
Healthcare Prism is a dedicated healthcare insights and outreach platform, operating as an extension of Precedence Research. We share relevant perspectives, industry developments, emerging trends, and research-driven insights across the global healthcare sector. Our content is built on the knowledge, research standards, and expertise of Precedence Research, with a focus on making healthcare information clear, accessible, and useful for industry professionals, businesses, researchers, and healthcare stakeholders. Healthcare Prism serves as a focused platform to extend the reach of Precedence Research’s healthcare insights and connect them with a broader professional audience.
You can place an order or ask any questions, please feel free to contact us at [email protected]
Quick Contact:
Europe Region: +44 778 256 0738
North America Region: +1 8044 4193 44
APAC Region: +91 9356 9282 04 and +65 31065601
Visit Our Website: Precedence Research – Advisory, Research & Reports